|
Miraculins
Inc., a biotechnology company engaged in the development of
products for selected cancers, announces the addition of Dr. John
Wilkins to its Scientific Advisory Board. Dr. Wilkins is currently a
Director of the Manitoba Centre for Proteomics and a Professor of
Immunology at the University of Manitoba.
Read More
|
|
Miraculins
Inc., a biotechnology company engaged in proteomics
research and development, congratulates the founding members of its
Scientific Advisory Board, Dr. Kenneth Standing and Dr. Werner Ens, for
breaking the second code critical to understanding the SARS virus.
Read More
|
|
Miraculins
Inc. a biotechnology company engaged in proteomic
research, announces the establishment of an expert Scientific Advisory
Board (SAB) with well respected and distinguished leaders in the field.
Read More
|
|
Miraculins Inc. announces that it has signed a Research
Agreement with the University of Manitoba utilizing its internationally
recognized time-of-flight (TOF) mass spectrometry laboratory, under the
direction of Dr. Kenneth Standing and Dr. Werner Ens.
Read More
|